Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.
Management
NamePosition
ZYZhang YingjunExecutive Director
JJJiang JuncaiExecutive Director
ZZZhang ZhiyongExecutive Director
ZYZhang YushuaiNon-Executive Director
TXTang XinfaNon-Executive Director
ZYZhu YingweiNon-Executive Director
LWLi WenjiaNon-Executive Director
LXLi XintianIndependent Non-Executive Director
MDMa DaweiIndependent Non-Executive Director
LALin AimeiIndependent Non-Executive Director
YTYe TaoIndependent Non-Executive Director
Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-18.
About this page
This page shows SUNSHINE PHARMA (06887) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.